Vaccines for HIV/AIDS Patients
HIV-infected patients should receive all routinely recommended inactivated vaccines according to standard schedules, while live vaccines are generally safe only when CD4 counts are ≥200 cells/μL. 1
Inactivated Vaccines (Safe for All HIV Patients)
All HIV-infected patients should receive the following inactivated vaccines regardless of CD4 count:
Influenza vaccine (inactivated) - annually (strong recommendation) 1, 2
Pneumococcal vaccines - sequential dosing required 1, 2:
- PCV13 (Prevnar 13) first
- PPSV23 (Pneumovax) ≥8 weeks later
- Second PPSV23 dose 5 years after first dose
- Note: Even patients with CD4 <200 cells/μL should receive PPSV23, though evidence is weaker 1
Tetanus/Diphtheria/Pertussis 1:
- Tdap once (substitute for one Td booster)
- Td every 10 years thereafter
Hepatitis B - consider high-dose (40 μg/dose) for adults 1, 2:
- Test for anti-HBs 1-2 months after completion
- If anti-HBs <10 mIU/mL, give second 3-dose series
Hepatitis A - recommended for all susceptible patients, especially men who have sex with men 1, 2
HPV vaccine - through age 26 years for both males and females 1, 3
Meningococcal vaccine (MCV4) - for children/adolescents with specific dosing schedules 1
Inactivated poliovirus (IPV) - if indicated (e.g., travel to endemic areas) 1, 2
Live Vaccines (CD4-Dependent)
The CD4 threshold of 200 cells/μL is the critical decision point for live vaccine safety:
Safe When CD4 ≥200 cells/μL:
MMR vaccine - for clinically stable HIV-infected children aged 1-13 years without severe immunosuppression 1
Varicella vaccine - two doses, 3 months apart, for patients without evidence of immunity 2, 4
Zoster vaccine (live attenuated) - consider for patients >60 years of age with CD4 ≥200 cells/μL 2, 4
- Important: The same CD4 threshold used for MMR and yellow fever applies here 4
Rotavirus vaccine - for HIV-exposed or infected infants according to standard schedule 1
Contraindicated:
- All live vaccines when CD4 <200 cells/μL 5, 6, 7
- Live attenuated influenza vaccine (LAIV) at any CD4 count 1, 2
Special Considerations
Timing matters: Ideally, vaccinate when CD4 counts are optimized on antiretroviral therapy, as immune reconstitution improves vaccine responses 7, 8. However, don't delay inactivated vaccines—give them at any CD4 count.
For children with HIV: Follow the same inactivated vaccine schedule, with additional considerations:
- Hib vaccine: one dose if >59 months and not previously vaccinated 1
- MCV4: two-dose primary series 2 months apart for ages 11-18 years 1
Common pitfall: Providers often unnecessarily withhold inactivated vaccines from patients with low CD4 counts. Remember: inactivated vaccines are safe at any CD4 count, though responses may be suboptimal 1, 8.
Hepatitis B non-responders: This is common in HIV patients. After initial series, check anti-HBs and consider repeating with high-dose vaccine if inadequate response 1, 2.